The Ukrainian medtech start-up, DrugCard, has entered into a partnership with the venture fund, New Nordic Ventures, securing a new financing round.
The start-up's CEO, Dmytro Horilyk, made this announcement.
Horilyk did not disclose the specific amount received from New Nordic Ventures.
"Even prior to formalising our collaboration, New Nordic Ventures provided us with valuable contacts in Latvia's pharmaceutical sector. This opened doors to key industry players in Latvia, granting us significant insights," he remarked.
Business angel Petro Chernyshov, who occasionally invests in early-stage Ukrainian start-ups, is also among DrugCard's investors.
DrugCard serves as an automatic platform for monitoring medical literature. It aids pharmaceutical companies by reducing costs, streamlining routine processes, and ensuring adherence to pharmacovigilance regulatory standards.